Onyia Jude
CIK 0001894425
Chief Scientific OfficerDirector
Filings
25
Latest Jun 2, 2026
Issuers covered
2
Showing
25 of 25
Page 1
Track record
12 of 14 open-market trades scored (86% price coverage) - 2 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 12 | 67% | +2.4% | +4.6% | +24.6% | -16.0% |
| 90 days | 12 | 42% | +1.1% | -1.3% | +29.8% | -19.8% |
| 180 days | 12 | 33% | -5.8% | -7.0% | +9.9% | -23.7% |
| 365 days | 10 | 20% | -12.6% | -10.7% | +12.4% | -38.1% |
Issuers
Companies where Onyia Jude has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| NBIX | Neurocrine Biosciences Inc | 21 | Jun 2, 2026 |
| VYGR | Voyager Therapeutics, Inc. | 4 | Jun 4, 2025 |
All filings
25 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|